Personal information

Other IDs

Scopus Author ID: 57212802262
Scopus Author ID: 24578198800

Activities

Collapse all

Employment (7)

Centre for Genomic Regulation: Barcelona, ES

2024-02-01 to present | Bioinformatician (Systems and Synthetic Biology)
Employment
Source: Self-asserted source
Miguel Torres Martin

Hospital Universitari Germans Trias i Pujol: Badalona, ES

2022-02-16 to 2024-01-31 | Bioinformatician (Genetics Service)
Employment
Source: Self-asserted source
Miguel Torres Martin

Institut d'Investigacions Biomèdiques August Pi i Sunyer: Barcelona, Catalunya, ES

2020-09-01 to 2022-02-15 | Bioinformatician
Employment
Source: Self-asserted source
Miguel Torres Martin

Icahn School of Medicine at Mount Sinai: New York, New York, US

2019-01-14 to 2020-09-01 | Bioinformatician (Liver)
Employment
Source: Self-asserted source
Miguel Torres Martin

University of Miami: Miami, Florida, US

2016-12-16 to 2019-01-13 | Postdoctoral Fellow (Human Genetics)
Employment
Source: Self-asserted source
Miguel Torres Martin

University of Michigan: Ann Arbor, Michigan, US

2015-04-01 to 2016-12-15 | Postdoctoral Fellow (Pathology)
Employment
Source: Self-asserted source
Miguel Torres Martin

Hospital Universitario La Paz: Madrid, Madrid, ES

2008-02-01 to 2014-07-14 | Predoctoral researcher (Research Unit)
Employment
Source: Self-asserted source
Miguel Torres Martin

Education and qualifications (2)

Universidad Autonoma de Madrid: Madrid, Madrid, ES

2008-02-01 to 2014-07-14 | PhD (Neuroscience)
Education
Source: Self-asserted source
Miguel Torres Martin

Universidad Autonoma de Madrid: Madrid, Madrid, ES

2002-09-01 to 2008-06-30 | Biology (Biology)
Education
Source: Self-asserted source
Miguel Torres Martin

Works (33)

Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma.

Molecular cancer therapeutics
2023-02-10 | Journal article | Author
DOI: 10.1158/1535-7163.mct-22-0335
PMID: 36780225
Contributors: Jordi Abril-Fornaguera; Laura Torrens; Carmen Andreu-Oller; Juan Carrillo Reixach; Alexander Rialdi; Ugne Balaseviciute; Roser Pinyol; Carla Montironi; Philipp Haber; Álvaro del Rio Álvarez et al.
Source: Self-asserted source
Miguel Torres Martin

Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype <i>in vitro</i>.

Molecular therapy. Nucleic acids
2022-11-04 | Journal article
DOI: 10.1016/j.omtn.2022.10.026
PMID: 36420221
PMC: PMC9678674
Contributors: Catasús N; Rosas I; Bonache S; Alejandro Negro; Torres-Martin M; Plana-Pla A; Salvador H; Serra E; Blanco I; Elisabeth Castellanos et al.
Source: Self-asserted source
Miguel Torres Martin

Hepatocellular Carcinoma in Mongolia Delineates Unique Molecular Traits and a Mutational Signature Associated with Environmental Agents.

Clinical cancer research : an official journal of the American Association for Cancer Research
2022-10-01 | Journal article | Author
DOI: 10.1158/1078-0432.ccr-22-0632
PMID: 35998012
PMC: PMC7613712
Contributors: Laura Torrens; Puigvehí M; Miguel Torres Martin; Wang H; Maeda M; Philipp Haber; Thais Leonel Couto; Mireia García-López; Roger Esteban-Fabró; Wei Qiang Leow et al.
Source: Self-asserted source
Miguel Torres Martin

Age alters the oncogenic trajectory toward luminal mammary tumors that activate unfolded proteins responses.

Aging cell
2022-09-15 | Journal article
DOI: 10.1111/acel.13665
PMID: 36111352
PMC: PMC9577951
Contributors: Jenkins EC; Chattopadhyay M; Gomez M; Denis Torre; Avi Ma'ayan; Torres-Martin M; Sia D; Doris Germain
Source: Self-asserted source
Miguel Torres Martin

Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma.

Gastroenterology
2022-09-12 | Journal article
DOI: 10.1053/j.gastro.2022.09.005
PMID: 36108710
Contributors: Haber PK; Florian Castet; Torres-Martin M; Andreu-Oller C; Puigvehí M; Miho M; Radu P; Dufour JF; Chris Verslype; Zimpel C et al.
Source: Self-asserted source
Miguel Torres Martin

Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications.

Gut
2022-05-18 | Journal article
DOI: 10.1136/gutjnl-2021-326514
PMID: 35584893
Contributors: Martin-Serrano MA; Benjamin Kepecs; Torres-Martin M; Bramel ER; Haber PK; Merritt E; Rialdi A; Param NJ; Maeda M; Lindblad KE et al.
Source: Self-asserted source
Miguel Torres Martin

Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification.

Gut
2022-02-23 | Journal article
DOI: 10.1136/gutjnl-2021-325918
PMID: 35197323
Contributors: Carla Montironi; Florian Castet; Haber PK; Roser Pinyol; Torres-Martin M; Laura Torrens; Mesropian A; Wang H; Puigvehi M; Maeda M et al.
Source: Self-asserted source
Miguel Torres Martin

Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinoma

Oncogene
2021 | Journal article
DOI: 10.1038/s41388-020-01519-1
EID:

2-s2.0-85093937508

Part of ISSN: 14765594 09509232
Contributors: von Felden, J.; Craig, A.J.; Garcia-Lezana, T.; Labgaa, I.; Haber, P.K.; D’Avola, D.; Asgharpour, A.; Dieterich, D.; Bonaccorso, A.; Torres-Martin, M. et al.
Source: Self-asserted source
Miguel Torres Martin via Scopus - Elsevier

p300 suppresses the transition of myelodysplastic syndromes to acute myeloid leukemia.

JCI insight
2021-10-08 | Journal article
DOI: 10.1172/jci.insight.138478
PMID: 34622806
PMC: PMC8525640
Contributors: Man N; Mas G; Karl DL; Sun J; Liu F; Yang Q; Torres-Martin M; Itonaga H; Martinez C; Chen S et al.
Source: Self-asserted source
Miguel Torres Martin

Immunomodulatory Effects of Lenvatinib Plus Anti-Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular Carcinoma.

Hepatology (Baltimore, Md.)
2021-09-27 | Journal article | Author
DOI: 10.1002/hep.32023
PMID: 34157147
Contributors: Laura Torrens; Carla Montironi; Marc Puigvehí; Agavni Mesropian; jack leslie; Haber PK; Maeda M; Ugne Balaseviciute; Catherine Willoughby; Jordi Abril-Fornaguera et al.
Source: Self-asserted source
Miguel Torres Martin

Cytokine-like protein 1-induced survival of monocytes suggests a combined strategy targeting MCL1 and MAPK in CMML.

Blood
2021-06-01 | Journal article | Author
DOI: 10.1182/blood.2020008729
PMID: 33690800
PMC: PMC8233685
Contributors: Sevin M; Debeurme F; Lucie Laplane; Badel S; Morabito M; Hannah Newman; Miguel Torres Martin; Qin Yang; bouchra badaoui; Orianne Wagner-Ballon et al.
Source: Self-asserted source
Miguel Torres Martin

Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis.

Journal of hepatology
2021-05-13 | Journal article
DOI: 10.1016/j.jhep.2021.04.049
PMID: 33992698
Contributors: Roser Pinyol; Torrecilla S; Wang H; Montironi C; Piqué-Gili M; Torres-Martin M; Wei-Qiang L; Catherine Willoughby; Pierluigi Ramadori; Andreu-Oller C et al.
Source: Self-asserted source
Miguel Torres Martin

Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma.

Journal of hepatology
2020-03-12 | Journal article
DOI: 10.1016/j.jhep.2020.03.008
PMID: 32173382
Source: Self-asserted source
Miguel Torres Martin
grade
Preferred source (of 2)‎

Multilayer intraclonal heterogeneity in chronic myelomonocytic leukemia.

Haematologica
2019-05-02 | Journal article
DOI: 10.3324/haematol.2018.208488
PMID: 31048357
Source: Self-asserted source
Miguel Torres Martin
grade
Preferred source (of 2)‎

TET2 Deficiency Causes Germinal Center Hyperplasia, Impairs Plasma Cell Differentiation, and Promotes B-cell Lymphomagenesis.

Cancer discovery
2018-10-01 | Journal article
DOI: 10.1158/2159-8290.cd-18-0657
PMID: 30274972
Source: Self-asserted source
Miguel Torres Martin
grade
Preferred source (of 2)‎

Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression.

Cell
2017-08-17 | Journal article
DOI: 10.1016/j.cell.2017.07.032
PMID: 28823558
PMC: PMC5755977
Source: Self-asserted source
Miguel Torres Martin
grade
Preferred source (of 2)‎

Whole exome sequencing in a case of sporadic multiple meningioma reveals shared NF2, FAM109B, and TPRXL mutations, together with unique SMARCB1 alterations in a subset of tumor nodules.

Cancer genetics
2015-04-11 | Journal article
DOI: 10.1016/j.cancergen.2015.03.012
PMID: 25981829
Source: Self-asserted source
Miguel Torres Martin
grade
Preferred source (of 2)‎

Genome-wide methylation analysis in vestibular schwannomas shows putative mechanisms of gene expression modulation and global hypomethylation at the HOX gene cluster.

Genes, chromosomes & cancer
2014-12-23 | Journal article
DOI: 10.1002/gcc.22232
PMID: 25533176
Source: Self-asserted source
Miguel Torres Martin
grade
Preferred source (of 2)‎

Global expression profile in low grade meningiomas and schwannomas shows upregulation of PDGFD, CDH1 and SLIT2 compared to their healthy tissue.

Oncology Reports
2014-10-03 | Journal article
DOI: 10.3892/or.2014.3526
PMID: 25333347
PMC: PMC4240498
Source: Self-asserted source
Miguel Torres Martin
grade
Preferred source (of 2)‎

Homozygous deletion of TNFRSF4, TP73, PPAP2B and DPYD at 1p and PDCD5 at 19q identified by multiplex ligation-dependent probe amplification (MLPA) analysis in pediatric anaplastic glioma with questionable oligodendroglial component.

Molecular cytogenetics
2014-01-06 | Journal article
DOI: 10.1186/1755-8166-7-1
PMID: 24387276
PMC: PMC3905963
Source: Self-asserted source
Miguel Torres Martin
grade
Preferred source (of 2)‎

Gene expression analysis of aberrant signaling pathways in meningiomas

Oncology Letters
2013 | Journal article
DOI: 10.3892/ol.2013.1363
EID:

2-s2.0-84878342675

Part of ISSN: 17921074 17921082
Contributors: Torres-Martín, M.; Martinez-Glez, V.; Peña-Granero, C.; Isla, A.; Lassaletta, L.; De Campos, J.M.; Pinto, G.R.; Burbano, R.R.; Meléndez, B.; Castresana, J.S. et al.
Source: Self-asserted source
Miguel Torres Martin via Scopus - Elsevier

Microarray analysis of gene expression in vestibular schwannomas reveals SPP1/MET signaling pathway and androgen receptor deregulation

International Journal of Oncology
2013 | Journal article
DOI: 10.3892/ijo.2013.1798
EID:

2-s2.0-84873667373

Part of ISSN: 10196439 17912423
Contributors: Torres-Martin, M.; Lassaletta, L.; San-Roman-Montero, J.; De Campos, J.M.; Isla, A.; Gavilan, J.; Melendez, B.; Pinto, G.R.; Burbano, R.R.; Castresana, J.S. et al.
Source: Self-asserted source
Miguel Torres Martin via Scopus - Elsevier

NF2 genetic alterations in sporadic vestibular schwannomas: clinical implications.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
2013-09-01 | Journal article
DOI: 10.1097/mao.0b013e318298ac79
PMID: 23921927
Source: Self-asserted source
Miguel Torres Martin
grade
Preferred source (of 2)‎

Global profiling in vestibular schwannomas shows critical deregulation of microRNAs and upregulation in those included in chromosomal region 14q32.

PloS one
2013-06-11 | Journal article
DOI: 10.1371/journal.pone.0065868
PMID: 23776562
PMC: PMC3679163
Source: Self-asserted source
Miguel Torres Martin
grade
Preferred source (of 2)‎

Schwannomas: Role of molecular genetics and epigenetic mechanisms

Tumors of the Central Nervous System, Volume 7: Meningiomas and Schwannomas
2012 | Book chapter
Part of DOI: 10.1007/978-94-007-2894-3_24
EID:

2-s2.0-85030992380
Contributors: Martinez-Glez, V.; Torres-Martin, M.; Castresana, J.S.; Lassaletta, L.; Rey, J.A.
Source: Self-asserted source
Miguel Torres Martin via Scopus - Elsevier

DNA copy gains of tumor-related genes in vestibular schwannoma.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
2012-11-21 | Journal article
DOI: 10.1007/s00405-012-2269-z
PMID: 23179934
Source: Self-asserted source
Miguel Torres Martin
grade
Preferred source (of 2)‎

Expression analysis of tumor-related genes involved in critical regulatory pathways in schwannomas.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
2012-10-02 | Journal article | Author
DOI: 10.1007/s12094-012-0937-5
PMID: 23054753
Contributors: Miguel Torres Martin; Martinez-Glez V; Peña-Granero C; Lassaletta L; Isla A; de Campos JM; Pinto GR; Burbano, R.R; Barbara Melendez; Castresana, JS et al.
Source: Self-asserted source
Miguel Torres Martin
grade
Preferred source (of 2)‎

The molecular biology of vestibular schwannomas and its association with hearing loss: a review.

Genetics research international
2012-02-20 | Journal article
DOI: 10.1155/2012/856157
PMID: 22567403
PMC: PMC3335540
Source: Self-asserted source
Miguel Torres Martin

Cyclin D1 expression and facial function outcome after vestibular schwannoma surgery.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
2011-01-01 | Journal article
DOI: 10.1097/mao.0b013e3182001cc8
PMID: 21131888
Source: Self-asserted source
Miguel Torres Martin
grade
Preferred source (of 2)‎

Genomic deletions at 1p and 14q are associated with an abnormal cDNA microarray gene expression pattern in meningiomas but not in schwannomas.

Cancer genetics and cytogenetics
2010-01-01 | Journal article
DOI: 10.1016/j.cancergencyto.2009.08.003
PMID: 19963129
Source: Self-asserted source
Miguel Torres Martin
grade
Preferred source (of 2)‎

cDNA microarray expression profile in vestibular schwannoma: correlation with clinical and radiological features.

Cancer genetics and cytogenetics
2009-10-01 | Journal article
DOI: 10.1016/j.cancergencyto.2009.06.016
PMID: 19781445
Source: Self-asserted source
Miguel Torres Martin
grade
Preferred source (of 2)‎

[Identification of genetic alterations by multiple ligation-dependent probe amplification (MLPA) analysis in oligodendrogliomas].

Neurocirugia (Asturias, Spain)
2009-04-01 | Journal article | Author
DOI: 10.1016/s1130-1473(09)70178-2
PMID: 19448956
Contributors: Franco-Hernández C; Martinez-Glez V; Miguel Torres Martin; de Campos JM; Isla A; Vaquero J; Casartelli C; Rey JA
Source: Self-asserted source
Miguel Torres Martin
grade
Preferred source (of 2)‎

Mutational analysis of the CITED4 gene in glioblastomas.

Cancer genetics and cytogenetics
2008-09-01 | Journal article
DOI: 10.1016/j.cancergencyto.2008.05.013
PMID: 18722883
Source: Self-asserted source
Miguel Torres Martin
grade
Preferred source (of 2)‎
How many people are using ORCID?